Moreover, Oster P et al. also found that H. pylori infection reduces the cancer immunotherapy efficacy of anti-CTLA4 and/or anti-PD-L1 therapy in the MC38 colon adenocarcinoma pre-clinical model. The gene discussed is CD274; the disease is cancer.